Intracranial Arteriosclerosis: Clinical Trials

9 trials for Intracranial Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Completed 9

Follow Intracranial Arteriosclerosis: new trials by email Literature Review of Intracranial Arteriosclerosis trials Research Report on Intracranial Arteriosclerosis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
N-831(Traneurocin) 10 mg QD, NA-831 (Traneurocin) 20 mg QD, NA-831 (Traneurocin) 40 mg QD - Mild Cognitive Impairment, Alzheimer Disease
Phase 2CompletedBiomed Industries, Inc.1262018-09-152020-06-30
Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia
TMBCZG, placebo - Vascular Dementia
Phase 2CompletedDongzhimen Hospital, Beijing1602017-07-282021-03-02
A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
BAC treatment, Matched vehicle - Alzheimer's Disease or Vascular Dementia
Phase 2CompletedCharsire Biotechnology Corp.802016-12-012022-10-13
Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial
Tadalafil, Placebo, Cognitive functioning tests - Dementia, Vascular
Phase 2CompletedSt George's, University of London552015-09-012022-10-27
Effect of Insulin Sensitizer Metformin on AD Biomarkers
Metformin, Placebos - Alzheimer's Disease, Vascular Dementia
Phase 2CompletedUniversity of Pennsylvania202013-01-012017-09-21
Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia
Fufangdanshen Tablets, Placebo - Vascular Dementia
Phase 2CompletedDongzhimen Hospital, Beijing2402012-09-012018-10-23
Delta-THC in Dementia
delta-9-tetrahydrocannabinol (delta-THC), Placebo, Acetaminophen - Behavioural Disturbances, Pain
Phase 2CompletedRadboud University Medical Center502012-06-012014-06-30
Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
STA-1, Ergoloid Mesylates tablet - Vascular Dementia
Phase 2CompletedSinphar Pharmaceutical Co., Ltd2402002-03-012011-11-21
Asymptomatic Carotid Artery Plaque Study (ACAPS)
aspirin, lovastatin - Cardiovascular Diseases, Carotid Stenosis
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)1988-05-012016-05-13

Narrower conditions

Dementia, Vascular (8)  ·  Alzheimer Disease (4)  ·  Dementia (2)  ·  Cardiovascular Diseases (1)  ·  Carotid Stenosis (1)  ·  Cerebrovascular Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Heart Diseases (1)  ·  Lewy Body Disease (1)  ·  Marijuana Abuse (1)  ·  Memory Disorders (1)  ·  Mental Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)

Broader conditions

Arterial Occlusive Diseases (9)  ·  Arteriosclerosis (9)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Intracranial Arterial Diseases (9)  ·  Nervous System Diseases (9)  ·  Cardiovascular Diseases (8)  ·  Cerebrovascular Disorders (8)  ·  Leukoencephalopathies (8)  ·  Vascular Diseases (8)  ·  Mental Disorders (7)  ·  Neurocognitive Disorders (7)  ·  Dementia (6)  ·  Neurodegenerative Diseases (3)

Interventions

Acetaminophen (1)  ·  Aspirin (1)  ·  Dronabinol (1)  ·  Ergoloid Mesylates (1)  ·  Lovastatin (1)  ·  Metformin (1)  ·  Neuropsychological Tests (1)  ·  Tadalafil (1)  ·  nabiximols (1)

Sponsors

Dongzhimen Hospital, Beijing (2)  ·  Biomed Industries, Inc. (1)  ·  Charsire Biotechnology Corp. (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Radboud University Medical Center (1)  ·  Sinphar Pharmaceutical Co., Ltd (1)  ·  St George's, University of London (1)  ·  University of Pennsylvania (1)

Countries

China (3)  ·  United States (2)  ·  Netherlands (1)  ·  New Zealand (1)  ·  United Kingdom (1)

Top investigators

Curt Furberg (1)  ·  Jeremy Dr Isaacs, MRCP PhD (1)  ·  JinZhou Tian, MD,PhD (1)  ·  Jing Shi, M.D (1)  ·  Jinzhou Tian, Ph.D, M.D (1)  ·  Lloyd Tran, PhD (1)  ·  Marcel Olde Rikkert, prof. dr. (1)  ·  Mark Espeland (1)  ·  Mingjun Yang (1)  ·  Stephen Thein (1)  ·  Steven E Arnold, MD (1)  ·  Willem Verhoeven, Prof. dr. (1)

Results publications

PMID 27266867, PMID 30572524, PMID 34532852, PMID 35080734, PMID 35135037, PMID 37565307, PMID 38160357

NIH funding

2015 (1), R01HL038194 (1)